Search research articles
Contact Us
Filters
Showing results (161-170 of 225) with videos related to
Page
of 23
Sort By:
Scientific Reports
|
November 2, 2022
Extreme obesity is a strong predictor for in-hospital mortality and the prevalence of long-COVID in severe COVID-19 patients with acute respiratory distress syndrome
Lars Heubner, Paul Leon Petrick, Andreas Güldner, et al.
Haematologica
|
March 9, 2019
Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study
Vincent Ten Cate, Anthonie W A Lensing, Jeffrey I Weitz, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis
|
February 26, 2024
Risk Profiles and Treatment Patterns in Atrial Fibrillation Patients with Chronic Kidney Disease Receiving or not Receiving Anticoagulation Therapy
Reinhold Kreutz, Gilbert Deray, Jürgen Floege, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
October 9, 2025
Indefinite anticoagulation with reduced-intensity direct oral anticoagulants in patients with splanchnic vein thrombosis. An international practice survey
Aurélien Delluc, Marc Carrier, Mandy Lauw, et al.
British Journal of Clinical Pharmacology
|
April 5, 2014
Safety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care--results from the Dresden NOAC registry
Jan Beyer-Westendorf, Vera Gelbricht, Kati Förster, et al.
Clinical and Translational Gastroenterology
|
August 16, 2018
Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis
Marco Senzolo, Nicoletta Riva, Francesco Dentali, et al.
Thrombosis Research
|
August 20, 2018
The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients
Hugo Ten Cate, Anthonie W A Lensing, Jeffrey I Weitz, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 26, 2025
Anticoagulant Management After Emergency Surgery or Major Bleeding in Anticoagulated Patients-Results of the Prospective RADOA Registry
Jana Last, Ingvild Birschmann, Simone Lindau, et al.
Thrombosis and Haemostasis
|
September 20, 2021
Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score
Maria A de Winter, Jannick A N Dorresteijn, Walter Ageno, et al.
Neurological Research and Practice
|
May 1, 2022
Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry
Waltraud Pfeilschifter, Edelgard Lindhoff-Last, Ali Alhashim, et al.
Page
of 23
Search research articles
Search
Showing results (161-170 of 225) with videos related to
Sort By:
Page
of 23
Scientific Reports
|
November 2, 2022
Extreme obesity is a strong predictor for in-hospital mortality and the prevalence of long-COVID in severe COVID-19 patients with acute respiratory distress syndrome
Lars Heubner, Paul Leon Petrick, Andreas Güldner, et al.
Haematologica
|
March 9, 2019
Extended anticoagulant therapy in venous thromboembolism: a balanced, fractional factorial, clinical vignette-based study
Vincent Ten Cate, Anthonie W A Lensing, Jeffrey I Weitz, et al.
TH Open : Companion Journal to Thrombosis and Haemostasis
|
February 26, 2024
Risk Profiles and Treatment Patterns in Atrial Fibrillation Patients with Chronic Kidney Disease Receiving or not Receiving Anticoagulation Therapy
Reinhold Kreutz, Gilbert Deray, Jürgen Floege, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
October 9, 2025
Indefinite anticoagulation with reduced-intensity direct oral anticoagulants in patients with splanchnic vein thrombosis. An international practice survey
Aurélien Delluc, Marc Carrier, Mandy Lauw, et al.
British Journal of Clinical Pharmacology
|
April 5, 2014
Safety of switching from vitamin K antagonists to dabigatran or rivaroxaban in daily care--results from the Dresden NOAC registry
Jan Beyer-Westendorf, Vera Gelbricht, Kati Förster, et al.
Clinical and Translational Gastroenterology
|
August 16, 2018
Long-Term Outcome of Splanchnic Vein Thrombosis in Cirrhosis
Marco Senzolo, Nicoletta Riva, Francesco Dentali, et al.
Thrombosis Research
|
August 20, 2018
The prothrombin time does not predict the risk of recurrent venous thromboembolism or major bleeding in rivaroxaban-treated patients
Hugo Ten Cate, Anthonie W A Lensing, Jeffrey I Weitz, et al.
Pharmaceuticals (Basel, Switzerland)
|
February 26, 2025
Anticoagulant Management After Emergency Surgery or Major Bleeding in Anticoagulated Patients-Results of the Prospective RADOA Registry
Jana Last, Ingvild Birschmann, Simone Lindau, et al.
Thrombosis and Haemostasis
|
September 20, 2021
Estimating Bleeding Risk in Patients with Cancer-Associated Thrombosis: Evaluation of Existing Risk Scores and Development of a New Risk Score
Maria A de Winter, Jannick A N Dorresteijn, Walter Ageno, et al.
Neurological Research and Practice
|
May 1, 2022
Intracranial bleeding under vitamin K antagonists or direct oral anticoagulants: results of the RADOA registry
Waltraud Pfeilschifter, Edelgard Lindhoff-Last, Ali Alhashim, et al.
Page
of 23